{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:27:51Z","timestamp":1746332871316},"reference-count":12,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>Ventriculoperitoneal (VP) shunt infections are seen in 3%\u201317% of patients with VP shunts. These infections may cause severe morbidity and mortality. Staphylococci are the most common cause of CSF shunt-associated infections, although gram-negative bacteria (especially multidrug-resistant [MDR] and extensive drug\u2013resistant [XDR] bacteria) also play an important role. Due to increased antibiotic resistance, sometimes off-label usage of antibiotics is considered. Tigecycline is one of these antibiotics. It should not be used unless there are no other antibiotic treatment options available, especially in children. It belongs to the glycylcycline class of antibiotic agents and inhibits protein translation in bacteria by binding to the 30S ribosomal subunit. The authors describe the case of a patient who had an XDR <jats:italic>Klebsiella pneumoniae<\/jats:italic>\u2013positive VP shunt infection. After removal of his VP shunt, an external ventricular drain was inserted, and the patient was treated with a combination of intravenous (1.2 mg\/kg\/day) and intraventricular (4 mg\/day) tigecycline in addition to his meropenem (120 mg\/kg\/day) treatment. On the 7th day of the combined therapy, his CSF culture was sterile. Because tigecycline distribution into the tissues is not sufficient with intravenous administration, combining it with intraventricular infusion can provide new treatment methods. However, further studies are needed for its use as a treatment method in children.<\/jats:p>","DOI":"10.3171\/2018.9.peds18470","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T23:50:52Z","timestamp":1542325852000},"page":"247-250","source":"Crossref","is-referenced-by-count":9,"title":["Intraventricular tigecycline for the treatment of shunt infection: a case in pediatrics"],"prefix":"10.3171","volume":"23","author":[{"given":"Berksu","family":"Curebal","sequence":"first","affiliation":[{"name":"Departments of Family Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazan","family":"Dalgic","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Bayraktar","sequence":"additional","affiliation":[{"name":"Microbiology, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Infect Dis (Lond)","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/23744235.2016.1155735","article-title":"Tigecycline: Alone or in combination?","volume":"48","author":"Cai Y","year":"2016","unstructured":"Cai Y, Bai N, Liu X, Liang B, Wang J, Wang R: Tigecycline: Alone or in combination? Infect Dis (Lond) 48:491\u2013502, 20162698210310.3109\/23744235.2016.1155735"},{"key":"b2","series-title":"BMJ Case Rep","doi-asserted-by":"publisher","first-page":"bcr0220113807","DOI":"10.1136\/bcr.02.2011.3807","article-title":"Multidrug-resistant Acinetobacter baumannii infection in children","volume":"2011","author":"De Luca M","year":"2011","unstructured":"De Luca M, Angelino G, Cal\u00f2 Carducci FI, Martino A, Bernardi S, Bernaschi P, : Multidrug-resistant Acinetobacter baumannii infection in children. BMJ Case Rep 2011:bcr0220113807, 201110.1136\/bcr.02.2011.3807"},{"key":"b3","series-title":"Pediatrics","doi-asserted-by":"publisher","first-page":"e20160963","DOI":"10.1542\/peds.2016-0963","article-title":"Tigecycline therapy in an infant for ventriculoperitoneal shunt meningitis","volume":"139","author":"Emiroglu M","year":"2017","unstructured":"Emiroglu M, Alkan G, Turk Dagi H: Tigecycline therapy in an infant for ventriculoperitoneal shunt meningitis. Pediatrics 139:e20160963, 201710.1542\/peds.2016-0963"},{"key":"b4","series-title":"Medicine (Baltimore)","doi-asserted-by":"publisher","first-page":"e7703","DOI":"10.1097\/MD.0000000000007703","article-title":"A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii","volume":"96","author":"Fang YQ","year":"2017","unstructured":"Fang YQ, Zhan RC, Jia W, Zhang BQ, Wang JJ: A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii. Medicine (Baltimore) 96:e7703, 201710.1097\/MD.000000000000770328767605"},{"key":"b5","series-title":"J Pediatric Infect Dis Soc","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/INF.0b013e3181c806d8","article-title":"Use of tigecycline in pediatric patients with infections predominantly due to extensively drug-resistant gram-negative bacteria","volume":"6","author":"Iosifidis E","year":"2017","unstructured":"Iosifidis E, Violaki A, Michalopoulou E, Volakli E, Diamanti E, Koliouskas D, : Use of tigecycline in pediatric patients with infections predominantly due to extensively drug-resistant gram-negative bacteria. J Pediatric Infect Dis Soc 6:123\u2013128, 20172700086610.1097\/INF.0b013e3181c806d8"},{"key":"b6","series-title":"Pediatr Infect Dis J","first-page":"379","article-title":"Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline","volume":"29","author":"Jaspan HB","year":"2010","unstructured":"Jaspan HB, Brothers AW, Campbell AJP, McGuire JK, Browd SR, Manley TJ, : Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 29:379\u2013381, 2010"},{"key":"b7","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3171\/2016.6.JNS16352","article-title":"First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii","volume":"127","author":"Lauretti L","year":"2017","unstructured":"Lauretti L, D\u2019Alessandris QG, Fantoni M, D\u2019Inzeo T, Fernandez E, Pallini R, : First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii. J Neurosurg 127:370\u2013373, 201710.3171\/2016.6.JNS1635227540902"},{"key":"b8","series-title":"Clin Microbiol Infect","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, : Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281, 201210.1111\/j.1469-0691.2011.03570.x21793988"},{"key":"b9","series-title":"Scand J Infect Dis","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/00365548.2013.837957","article-title":"Cerebrospinal fluid penetration of tigecycline","volume":"46","author":"Pallotto C","year":"2014","unstructured":"Pallotto C, Fiorio M, D\u2019Avolio A, Sgrelli A, Baldelli F, Di Perri G, : Cerebrospinal fluid penetration of tigecycline. Scand J Infect Dis 46:69\u201372, 201410.3109\/00365548.2013.83795724131423"},{"key":"b10","series-title":"Eur J Hosp Pharm","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/ejhpharm-2016-000972","article-title":"Intrathecal injection of tigecycline in treatment of multidrug-resistant Acinetobacter baumannii meningitis: a case report","volume":"24","author":"Wang L","year":"2017","unstructured":"Wang L, Zhang J, Yu X, Wang J, Cheng L, Hu S, : Intrathecal injection of tigecycline in treatment of multidrug-resistant Acinetobacter baumannii meningitis: a case report. Eur J Hosp Pharm 24:182\u2013184, 201710.1136\/ejhpharm-2016-000972"},{"key":"b11","series-title":"Hong Kong Med J","first-page":"410","article-title":"Primary ventriculoperitoneal shunting outcomes: a multicentre clinical audit for shunt infection and its risk factors","volume":"22","author":"Woo PYM","year":"2016","unstructured":"Woo PYM, Wong HT, Pu JKS, Wong WK, Wong LY, Lee MW, : Primary ventriculoperitoneal shunting outcomes: a multicentre clinical audit for shunt infection and its risk factors. Hong Kong Med J 22:410\u2013419, 201627562986"},{"key":"b12","series-title":"J Chemother","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/1120009X.2017.1338846","article-title":"Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report","volume":"30","author":"Wu Y","year":"2018","unstructured":"Wu Y, Chen K, Zhao J, Wang Q, Zhou J: Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report. J Chemother 30:49\u201352, 201810.1080\/1120009X.2017.133884628614982"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/23\/2\/article-p247.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/23\/2\/article-p247.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/23\/2\/article-p247.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T13:29:43Z","timestamp":1681565383000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/23\/2\/article-p247.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":12,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2018.9.peds18470","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}